CORDIPIN RETARD TABLET 20MG

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

NIFEDIPINE

Boleh didapati daripada:

PAHANG PHARMACY SDN. BHD.

INN (Nama Antarabangsa):

NIFEDIPINE

Unit dalam pakej:

30Tablet Tablets; 90 Tablet Tablets

Dikeluarkan oleh:

KRKA

Risalah maklumat

_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
CORDIPIN RETARD TABLET
Nifedipine (20 mg)
_ _
1
WHAT IS IN THIS LEAFLET
1.
What Cordipin retard is used for
2.
How Cordipin retard works
3.
Before you use Cordipin retard
4.
How to use Cordipin retard
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of Cordipin
retard
8.
Product Description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
WHAT _CORDIPIN RETARD_ IS USED FOR
The drug is intended for treatment of all
kinds of high blood pressure and all
kinds of angina pectoris (chest pain),
particularly vasospastic and chronic
stable one.
HOW _CORDIPIN RETARD_ WORKS
Nifedipine inhibits the influx of
calcium into the cells of the heart
muscle and the muscle cells in the walls
of arteries. It decreases the
consumption of oxygen directly by
reducing heart work. The oxygen
demand is also indirectly decreased as
the heart is relieved.
Cordipin retard tablet is a prolong-
release tablet. The release of nifedipine
is slower so nifedipine achieves the
maximum concentrations in 2 to 4
hours and its effect persists for 10 to
12 hours.
BEFORE YOU USE _CORDIPIN RETARD_
-
_When you must not use it _

if you are allergic (hypersensitive)
to nifedipine or any of the other
ingredients of Cordipin retard;

if you have ever had an allergic
reaction to similar drugs
(dihydropyridines);

if you have impaired aortic valve
(aortic stenosis);

if you have a disorder of porphyrin
metabolism (a type of metabolic
disorder called porphyria);

if you are pregnant or are breast-
feeding.
Patients with insufficient blood
perfusion of organs, poor oxygen
supply and too low blood pressure
(cardiogenic shock) must not take the
medicine.
_ _
-
_Before you start use it _
Contact your doctor immediately:

if you feel pain or tightness in your
chest after the first dose of Cordipin
retard;

if during treatment with Cordipin
retard you suddenly experience
more frequent, stronger and longer
attacks of chest pain both at rest and
during physical ac

Ciri produk

Information for patients
1
CORDIPIN
® RETARD
PROLONGED RELEASE TABLETS 20 MG
NIFEDIPINE
COMPOSITION
1 prolonged release tablet contains 20 mg nifedipine.
ACTION
Nifedipine inhibits the influx of calcium into the myocardial cells
and the smooth muscle cells of
arteries. It decreases the consumption of oxygen directly by reducing
heart work. The oxygen
demand is also indirectly decreased as the heart is relieved.
The release of nifedipine from prolonged release tablets is slower so
nifedipine achieves the
maximum concentrations in 2 to 4 hours and its effect persists for 10
to 12 hours.
INDICATIONS
The drug is intended for treatment of all kinds of high blood pressure
and all kinds of angina
pectoris, particularly vasospastic and chronic stable one.
CONTRAINDICATIONS
The drug should not be used by patients hypersensitive to nifedipine
or any of the other
ingredients of the drug, by patients with cardiogenic shock, advanced
aortic stenosis, porphyria
and by nursing mothers.
PRECAUTIONS
Especially at the beginning of treatment and if certain groups
intended for treatment of high
blood pressure (beta blockers) are taken concomitantly, blood pressure
may fall substantially,
which some patients tolerate poorly. In patients taking beta blockers,
heart failure may occur
after the introduction of nifedipine therapy. The doctor will make
more frequent appointments
for control examinations, which you should pass regularly, even if you
feel well.
If you suffer from severe heart diseases (hypertrophic cardiomyopathy,
unstable angina pectoris),
diabetes, severe hepatic dysfunction or severe pulmonary hypertension
and you are an elderly
person, you will be closely monitored by your doctor during the
introduction of nifedipine
therapy.
In patients with severe coronary disease, more frequent attacks of
angina pectoris may occur at
the beginning of treatment. Mild to moderate peripheral edema,
typically associated with arterial
vasodilation and not due to left ventricular dysfunction, occurs in
about one in ten patients
treated wi